Publications by authors named "Anna Lucania"

Claim this Profile
R
Routine Imaging Surveillance After Frontline ABVD Improves Outcome in High-Risk Hodgkin Lymphoma.
Novella Pugliese, Marco Picardi, Annamaria Vincenzi, Claudia Giordano, Anna Lucania

Cancers (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus communication strategies to improve doctor-patient relationship in paediatric severe asthma.
Antonietta Cappuccio, , Filomena Bugliaro, Silvia Maria Elena Caimmi, Valeria Caldarelli, Anna Lucania

Ital J Pediatr· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study).
Vittorio Stefoni, Cinzia Pellegrini, Alessandro Broccoli, Luca Baldini, Monica Tani, Anna Lucania

Oncologist· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic spontaneous urticaria or autoinflammatory disease? The therapeutic effect of omalizumab in a pediatric patient.
Maria Cristina Maggio, Anna Lucania, Mirella Collura, Giovanni Corsello

J Dermatolog Treat· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined use of free light chain and heavy/light chain ratios allow diagnosis and monitoring of patients with monoclonal gammopathies: Experience of a single institute, with three exemplar case reports.
Alfredo Gagliardi, Claudio Carbone, Angela Russo, Rosanna Cuccurullo, Anna Lucania

Oncol Lett· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathy.
Gaetano Corazzelli, Ferdinando Frigeri, Manuela Arcamone, Anna Lucania, Maria Rosariavilla

Br J Haematol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-pegylated liposomal doxorubicin (Myocet®) in patients with poor-risk aggressive B-cell non-Hodgkin lymphoma.
Matteo Dell'Olio, Rosario Potito Scalzulli, Grazia Sanpaolo, Michele Nobile, Francesco Saverio Mantuano, Anna Lucania

Leuk Lymphoma· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Congenital and acquired thrombotic risk factors in lymphoma patients bearing upper extremities deep venous thrombosis: a preliminary report.
Pierpaolo Di Micco, Alferio Niglio, Amalia De Renzo, Anna Lucania, Rosanna Di Fiore

J Transl Med· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis